Malaysian Genomics Resource Centre Berhad, via its wholly-owned subsidiary MGRC Therapeutics Sdn Bhd, is partnering with IMU University on its graduate trainee programme.
The genomics and biopharmaceutical specialist said the initiative is focused on fostering industry education excellence and training of genomics and biopharmaceutical professionals.
The graduate trainee programme offers IMU graduates from the Bachelor of Applied Science (Hons) in Medical Biotechnology and Bachelor of Science (Hons) in Biomedical Science an opportunity to gain hands-on experience in the genomics and biopharmaceutical industry.
Selected graduates will benefit from a holistic career pathway leveraging MGRC’s extensive ecosystem.
Participants will receive mentorship from industry experts, exposure to cutting-edge technologies, and involvement in ground breaking research projects.
The programme is designed to cultivate essential skills such as critical thinking, problem-solving and innovative thinking, preparing graduates for leadership roles in their future careers.
It serves as a training ground for students, offering a smooth transition to the workforce with the possibility of full employment based on performance.
Malaysian Genomics executive chairman Azri Azerai said the collaboration with IMU University reflects their dedication to nurturing young talent and supporting the development of future leaders in the genomics and biopharmaceutical sectors.
“By providing practical training and career opportunities, we are not only contributing to the personal and professional growth of these graduates but also reinforcing our commitment to sustainable and responsible business practices,” he said.
IMU University group managing director Prof Gerard George said theinitiative is a testament to their ongoing commitment to providing their students with the best possible start to their careers.
“By partnering with a leading industry player like MGRC, we can ensure that our graduates are equipped with the practical skills and industry knowledge necessary to excel in the rapidly evolving fields of genomics and biopharmaceuticals.”
